Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,761
archived clinical trials in
Osteoporosis

Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
58
mi
from 91732
Murrieta, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
58
mi
from 91732
Murrieta, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
67
mi
from 91732
Oxnard, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
67
mi
from 91732
Oxnard, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
144
mi
from 91732
Santa Maria, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
144
mi
from 91732
Santa Maria, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
26
mi
from 91732
Santa Monica, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
26
mi
from 91732
Santa Monica, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
353
mi
from 91732
South Lake Tahoe, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
353
mi
from 91732
South Lake Tahoe, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
49
mi
from 91732
Victorville, CA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
49
mi
from 91732
Victorville, CA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
812
mi
from 91732
Lakewood, CO
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
812
mi
from 91732
Lakewood, CO
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2472
mi
from 91732
Trumbull, CT
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2472
mi
from 91732
Trumbull, CT
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2204
mi
from 91732
Fort Myers, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2204
mi
from 91732
Fort Myers, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2315
mi
from 91732
Hollywood, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2315
mi
from 91732
Hollywood, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2127
mi
from 91732
Jacksonville, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2127
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2187
mi
from 91732
Kissimmee, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2187
mi
from 91732
Kissimmee, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2306
mi
from 91732
Pembroke Pines, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2306
mi
from 91732
Pembroke Pines, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2205
mi
from 91732
Sebring, FL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2205
mi
from 91732
Sebring, FL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1943
mi
from 91732
Gainesville, GA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1943
mi
from 91732
Gainesville, GA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1907
mi
from 91732
Woodstock, GA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1907
mi
from 91732
Woodstock, GA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1574
mi
from 91732
Alton, IL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1574
mi
from 91732
Alton, IL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1663
mi
from 91732
Rockford, IL
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1663
mi
from 91732
Rockford, IL
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1580
mi
from 91732
Bettendorf, IA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1580
mi
from 91732
Bettendorf, IA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1966
mi
from 91732
Detroit, MI
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1966
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from 91732
East Lansing, MI
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from 91732
East Lansing, MI
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1894
mi
from 91732
Lansing, MI
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1894
mi
from 91732
Lansing, MI
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1569
mi
from 91732
Woodbury, MN
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1569
mi
from 91732
Woodbury, MN
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1400
mi
from 91732
Springfield, MO
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1400
mi
from 91732
Springfield, MO
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
208
mi
from 91732
Las Vegas, NV
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
208
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Research Site
2414
mi
from 91732
Butler, NJ
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Research Site
2414
mi
from 91732
Butler, NJ
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Research Site
2403
mi
from 91732
Dover, NJ
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Research Site
2403
mi
from 91732
Dover, NJ
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
649
mi
from 91732
Albuquerque, NM
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
649
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2434
mi
from 91732
Brooklyn, NY
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2434
mi
from 91732
Brooklyn, NY
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2461
mi
from 91732
Plainview, NY
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2461
mi
from 91732
Plainview, NY
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from 91732
Asheboro, NC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from 91732
Asheboro, NC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2102
mi
from 91732
Charlotte, NC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2224
mi
from 91732
Tabor City, NC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2224
mi
from 91732
Tabor City, NC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2126
mi
from 91732
Winston-Salem, NC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2126
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2040
mi
from 91732
Akron, OH
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2040
mi
from 91732
Akron, OH
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1898
mi
from 91732
Centerville, OH
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1898
mi
from 91732
Centerville, OH
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1880
mi
from 91732
Cincinnati, OH
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1885
mi
from 91732
Middletown, OH
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1885
mi
from 91732
Middletown, OH
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
712
mi
from 91732
Bend, OR
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
712
mi
from 91732
Bend, OR
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2200
mi
from 91732
Duncansville, PA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2200
mi
from 91732
Duncansville, PA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2367
mi
from 91732
Lansdale, PA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2367
mi
from 91732
Lansdale, PA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2234
mi
from 91732
Myrtle Beach, SC
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2234
mi
from 91732
Myrtle Beach, SC
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1653
mi
from 91732
Jackson, TN
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1653
mi
from 91732
Jackson, TN
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1213
mi
from 91732
Austin, TX
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1213
mi
from 91732
Austin, TX
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1203
mi
from 91732
Southlake, TX
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1203
mi
from 91732
Southlake, TX
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2340
mi
from 91732
Chesapeake, VA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2340
mi
from 91732
Chesapeake, VA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2257
mi
from 91732
Midlothian, VA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2257
mi
from 91732
Midlothian, VA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2219
mi
from 91732
Winchester, VA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2219
mi
from 91732
Winchester, VA
Click here to add this to my saved trials
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
939
mi
from 91732
Spokane, WA
Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis
Prospective Observational Study to Evaluate Persistence With Prolia® (Denosumab) in Postmenopausal Women With Osteoporosis in Routine Clinical Practice
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
939
mi
from 91732
Spokane, WA
Click here to add this to my saved trials